Mary T Szela
Director; Director, CEO and President · 7 filings · Latest: Jun 30, 2026
Absci Corp
Kura Oncology, Inc.
TriSalus Life Sciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TLSI | Mary T Szela | Director, CEO and President | May 15, 2026 | Purchase | $2.59 | 39,682 | $102.8K | 1,065,215 | |
TLSI | Mary T Szela | Director, CEO and President | Mar 17, 2026 | Sale | $3.85 | 15,944 | $61.4K | 752,987 | |
TLSI | Mary T Szela | Director, CEO and President | Mar 11, 2026 | Sale | $4.13 | 4,358 | $18.0K | 768,931 | |
TLSI | Mary T Szela | Director, CEO and President | Feb 23, 2026 | Purchase | $4.10 | 30,487 | $125.0K | 773,289 |